Ultrasound Elastography in Patients With Rectal Cancer
Launched by VEJLE HOSPITAL · Jun 21, 2011
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with biopsy verified adenocarcinoma in the rectum ≤ 10 cm from the anal verge.
- • 2. T3/4 tumor assessed by transrectal ultrasound and MR, and CRMMR \< 5 mm.
- • 3. Life expectancy of more than 3 months.
- • 4. Age ≥18 years.
- • 5. Performance status ≤ 2 according to WHO.
- • 6. Patient able to observe protocol guidelines.
- • 7. Signed informed consent.
- Exclusion Criteria:
- • 1. Previous radiation treatment for the pelvis.
- • 2. Known distant metastases.
- • 3. Serious disease contraindicating treatment, including cardiovascular disease.
- • 4. Other malignant disease apart from curativly treated non-melanotic skin cancer and previously treated carcinoma in situ cervicis uteri.
- • 5. Pacemaker
- • 6. other disease making the patient unfit for study participation as assessed by investigator
About Vejle Hospital
Vejle Hospital is a leading healthcare institution in Denmark, dedicated to advancing medical research and enhancing patient care through innovative clinical trials. With a focus on multidisciplinary collaboration, Vejle Hospital leverages its state-of-the-art facilities and experienced research teams to conduct rigorous studies across various therapeutic areas. Committed to ethical standards and patient safety, the hospital aims to contribute valuable insights to the medical community, ultimately improving treatment outcomes and healthcare practices. Through its clinical trial initiatives, Vejle Hospital strives to foster a culture of scientific excellence and drive advancements in health and medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vejle, , Denmark
Vejle, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials